Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.710
0.00 (0.00%)
At close: Mar 6, 2026
10.08%
Market Cap 157.74M
Revenue (ttm) 223.68M
Net Income (ttm) 14.16M
Shares Out 222.16M
EPS (ttm) 0.05
PE Ratio 15.07
Forward PE n/a
Dividend 0.03 (3.52%)
Ex-Dividend Date Jan 16, 2026
Volume 140,000
Average Volume 106,690
Open 0.700
Previous Close n/a
Day's Range 0.700 - 0.710
52-Week Range 0.580 - 0.735
Beta 0.14
RSI 55.22
Earnings Date Feb 20, 2026

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services. It also conducts research and development in biotechnology; distributes human healthcare and related products; wholesales and distributes pharmaceu... [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 205
Stock Exchange Bursa Malaysia
Ticker Symbol RHONEMA
Full Company Profile

Financial Performance

In 2025, Rhone Ma Holdings Berhad's revenue was 223.68 million, an increase of 5.81% compared to the previous year's 211.41 million. Earnings were 14.16 million, an increase of 15.07%.

Financial Statements

News

There is no news available yet.